PrivateKeenova Therapeutics plc Silver Point Capital L.P. bought Keenova Therapeutics plc shares — SEC Form 4BUY

Silver Point Capital L.P., 10% Owner (NONE), bought 290,000 shares at $93.75 ($27.2M) on 2025-11-10, disclosed to the SEC on 2025-11-12.

SEC EDGAR Filing

0001193125-25-278319

View on SEC EDGAR

Trade context

Open-market purchase of $27.2M NONE by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.

10% Owner PurchaseOpportunistic BuyUnusually Large TradeLargest Purchase Ever

Trade Context

•7 proven sellers (57% accuracy) also selling this stock
•Increased holdings by 7%
•Largest purchase ever, out of 7
•54 other insiders also purchased in last 30 days
•Made 10 straight sales before this purchase

Filing Info

Filed2025-11-12

Traded2025-11-10

Accession0001193125-25-278319

SourceSEC EDGAR (Historical)

Insider

NameSilver Point Capital L.P.

Title10% Owner

PIT GradeInsiderC

Score—

View Company View Insider

Related Trades by This Insider

Ticker	Type	Filed	Value	7d Stock	Filing
QVCG	SELL	2026-09-10	$26.0M	—	Filing →
QVCG	SELL	2026-09-08	$11.8M	—

Get an email when an insider at NONE files

Free account. Follow NONE and up to 10 more companies.

Follow NONE for free

PrivateKeenova Therapeutics plc Silver Point Capital L.P. bought Keenova Therapeutics plc shares — SEC Form 4BUY

Trade Context

Filing Info

Insider

Related Trades by This Insider

Trade Details

Outcomes